Markus Meier, assistant director for healthcare enforcement in the Federal Trade Commission's Bureau of Competition, outlines the agency's view on accountable care organizations, hospitals' M&A activity, and drugmakers' play-for-delay tactics. See the edited transcript.
FTC's Markus Meier outlines agency stance on ACOs, mergers, pay-for-delay
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.